When I hear someone say “complex carbs,” the first images that come to mind are pizza and pasta — and the inevitable post-meal glucose spike and lingering high blood sugars that follow. But a biomedical pharma company in New Hampshire is working on a fix for this — a chewable tablet that looks similar to […]
Afrezza is an ultra-rapid-acting powder designed to be taken before a meal. It is designed for adults with type 1 or type 2 diabetes, but it is not yet approved for kids. It’s important to understand that Afrezza is not a stand-alone drug. This novel delivery system was created to control post-meal blood sugar spikes, […]
The Consensus Conference on Glucose Monitoring took place in Washington D.C. to discuss quality and safety of glucose monitoring. Discussion topics included the need for greater post-market surveillance, the DTS Surveillance Program, the FDA, and two CGM Medicare bills currently in Congress.
Note that there was a ton of hoopla about this product when it came out last Fall, because the mainstream media jumped all over it as “the first-ever artificial pancreas,” which it is not. But it is a step in the right direction, as it pairs the functions of an insulin pump and CGM and […]
We’ve gotten word that the FDA has approved the exciting Dexcom SHARE system, the first mobile device approval of its kind that allows data from a continuous glucose monitor to be beamed via Bluetooth wireless technology to as many as five smartphones anywhere!
Stevia, an FDA-approved sweetener, attempts to be the answer. It’s becoming increasingly popular, blending in between the pink, blue and yellow packets at coffee shops, even making its way into brand name soda products.
The Vigilant folks have pretty smooth marketing materials that state: “Bee helps patients by creating a log book of insulin injection and blood sugar level data which they may share with their loved ones and healthcare providers.” And that’s true, to an extent.
This month Glooko announced the launch of MeterSync Blue, a small device that allows users to upload glucose meter data to Android and iPhone apps via Bluetooth. MeterSync Blue is compatible with over 30 meters, including many made by Abbott, Bayer, LifeScan, and Roche – see the list here.
At the recent Health 2.0 conference, Medtronic demoed its in-development Guardian Mobile system, which will send real-time CGM readings straight from a transmitter to a smartphone app via Bluetooth. Medtronic believes the product will only require a sensor, a Bluetooth enabled transmitter, and a smart phone – no receiver required.
Different types of insulin are used to manage type 1 diabetes with insulin injections. Long-acting insulin takes about one hour to begin lowering blood sugar levels and lasts up to 26 hours, while intermediate-acting insulin takes one to three hours to begin lowering blood sugar levels and lasts up to 16 hours.
Last month, we reported on the Diabetes Technology Society’s progress on a post-market surveillance program to keep tabs on the accuracy of glucose meters already on the market. We’re happy to bring you an overview report on the joint AACE/ACA conference straight from Bennet, who was of course there representing our D-Community and taking part […]
Glooko (Palo Alto, CA) just released its MeterSync Blue device that connects over 30 different glucometers to its smartphone app via Bluetooth. Previously, Glooko provided a cable that was the interface between a blood glucose meter and a smartphone running the company’s app. The new device hopefully will make tracking and sharing of blood glucose […]
Study results showed that patients on insulin pumps had a 29% reduction in mortality rate compared to patients on multiple daily insulin injection. Patients on insulin pumps had 43% lower risk of fatal cardiovascular disease compared to those on insulin injections.
A diabetes drug delivered continuously from a small implantable pump resulted in a marked and sustained reduction in blood sugar in patients in two studies, potentially setting the stage for a once-a-year treatment option to manage the disease.
While we’re talking about new Bluetooth-enabled diabetes tools… Yesterday Glooko, makers of the popular cable that allows users to easily download meter readings from a multitude of FDA-cleared glucose meters into their mobile device, launched something called “MeterSync Blue” that will reportedly “bluetooth-enable tens of millions of blood glucose meters worldwide” (!)
When new diabetes products are launched, we’re always happy to offer some personal perspective into what it’s really like to use them in the real world. Today, our correspondent Wil Dubois offers some insight on the new Roche Accu-Chek Aviva Expert meter that was FDA-approved about a year ago, and just recently in mid-September became […]
For many people with Type 1 diabetes, Lantus has been a godsend, a long-acting, slow-release basal insulin that has helped thousands of people achieve better glycemic control. Since Lantus hit the market at the turn of the 21st century, it has also become a goldmine for its parent company, Sanofi, racking up nearly $8 billion […]
Are you trying to be the “perfect” person with diabetes? If so, you could be setting yourself up to feel like a failure. Why? Because there is no such thing as the perfect person with diabetes. Setting a goal to have “perfect” blood glucose control is admirable, but the concept of “perfect” blood glucose control […]
Swedish researchers have found that insulin pump users have better medical outcomes than those who use multiple daily injections. Also in recent news, The Juvenile Diabetes Research Foundation has awarded a $500,000 grant for research on an implantable encapsulation device that releases insulin-producing beta cells in the bloodstream of people with Type 1 diabetes.
Updates on the European Approval to Launch the Freestyle Libre System, FDA “Tentative Approval” of BI/Lilly’s insulin glargine Basaglar and NIH $20 Million commitment for Pivotal Artificial Pancreas Studies.